Influence of tenofovir exposure in utero on primary dentition

Eur J Pediatr. 2020 Nov;179(11):1761-1768. doi: 10.1007/s00431-020-03660-1. Epub 2020 May 19.

Abstract

Tenofovir disoxoproxil fumarate (TDF) is recommended for antiretroviral treatment for pregnant women living with HIV. As a comparative method to study bone density, we investigated the influence of in utero tenofovir exposure on the prevalence and distribution of developmental defects of enamel (DDE) in the primary dentition, as the mineralization process in teeth is higher and more complex and thus more vulnerable. HIV-exposed children with in utero exposition to tenofovir were included in this prospective observational single-center study. Dental status and enamel defects were assessed by an experienced dentist following a standardized protocol. Further information was collected using a standardized questionnaire, available in German and English. The prevalence of developmental defects in children with intrauterine tenofovir exposure was compared with literature data from a recent study of 377 healthy children in Germany and literature data from a study of 1221 healthy African children. Thirty-one children (mean age 2.1 ± 0.3 years; 41.9% female) were included. Median tenofovir exposure in utero was 28 weeks (mean ± 10.52 SD). Prevalence of developmental defects in the primary dentition in tenofovir-exposed children was similar compared to data of unexposed children (16.1% vs. 5.3%, p = 0.051 (compared to German cohort); 16.1% vs. 33.3%, p = 0.068 (compared to African cohort)).Conclusion: HIV-uninfected infants with in utero exposure to TDF showed no significant differences in the prevalence of DDE in comparison to cross-sectional data of HIV- and TDF-unexposed children; thus, the in utero exposure to TDF did not negatively influence the prevalence or distribution of DDE. What is Known: • There are no data available on the prevalence of developmental defects of enamel (DDE) in the primary dentition in intrauterine HIV- and tenofovir-exposed children. • Conclusions can be drawn from intrauterine milk tooth development to bone development and mineralization. What is New: • Prevalence of developmental defects in the primary dentition in tenofovir-exposed children was similar compared to data of unexposed children. • Preterm birth and hospitalization did not show a significant association on the prevalence of developmental defects in the primary dentition.

Keywords: ART; Bone; HIV; Hypomineralization; Hypoplasia; Pregnancy; Uninfected.

Publication types

  • Observational Study

MeSH terms

  • Anti-HIV Agents* / adverse effects
  • Child
  • Child, Preschool
  • Cross-Sectional Studies
  • Female
  • Germany / epidemiology
  • HIV Infections* / drug therapy
  • HIV Infections* / epidemiology
  • Humans
  • Infant
  • Infant, Newborn
  • Male
  • Pregnancy
  • Premature Birth*
  • Tenofovir / adverse effects
  • Tooth, Deciduous

Substances

  • Anti-HIV Agents
  • Tenofovir